- Corporate Officers - L
- Lamattina John L
Insider Trading History of Lamattina John L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lamattina John L since 2005.
This trader's CIK number is 1216074.
At the time of last reporting, Lamattina John L was the Director of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
Note that in the past
LAMATTINA JOHN L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Lamattina John L
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | LGND | 0 | $0 | 2,406 | $297,501 | 2,406 | $125,833 |
2021 | LGND | 0 | $0 | 4,835 | $782,578 | 4,835 | $156,170 |
2019 | LGND | 0 | $0 | 0 | $0 | 2,500 | $80,750 |
2018 | LGND | 0 | $0 | 10,670 | $2,164,935 | 10,670 | $125,657 |
2017 | LGND | 0 | $0 | 4,000 | $559,160 | 4,000 | $40,480 |
2014 | LGND | 0 | $0 | 5,000 | $394,150 | 5,000 | $44,850 |
2011 | LGND | 10,000 | $98,190 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pfizer Inc (PFE) by Lamattina John L
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2007 | PFE | 0 | $0 | 49,866 | $1,321,279 | 13,800 | $253,230 |
2005 | PFE | 0 | $0 | 39,789 | $1,106,731 | 0 | $0 |
Yearly summary of insider trading at Human Genome Sciences Inc (HGSI) by Lamattina John L
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2011 | HGSI | 0 | $0 | 0 | $0 | 12,009 | $25,098 |
2009 | HGSI | 10,000 | $7,190 | 0 | $0 | 0 | $0 |
2008 | HGSI | 20,000 | $43,700 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunome Inc. (IMNM) by Lamattina John L
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | IMNM | 5,440 | $100,694 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Lamattina John L:
1. Ligand Pharmaceuticals Inc (LGND)
2. Pfizer Inc (PFE)
3. Human Genome Sciences Inc (HGSI)
4. Immunome Inc. (IMNM)
Table 1. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Lamattina John L
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-11-27 | LGND | Option Ex | 2,406 | 52.30 | 125,833 |
2024-11-27 | LGND | Sale | 2,406 | 123.65 | 297,501 |
2021-11-16 | LGND | Option Ex | 4,835 | 32.30 | 156,170 |
2021-11-16 | LGND | Sale | 4,835 | 161.86 | 782,578 |
2019-08-01 | LGND | Option Ex | 2,500 | 32.30 | 80,750 |
2018-09-04 | LGND | Sale | 3,335 | 254.96 | 850,291 |
2018-09-04 | LGND | Option Ex | 3,335 | 12.53 | 41,787 |
2018-06-04 | LGND | Option Ex | 4,000 | 12.53 | 50,120 |
2018-06-04 | LGND | Sale | 4,000 | 194.51 | 778,040 |
2018-03-05 | LGND | Option Ex | 3,335 | 10.12 | 33,750 |
2018-03-05 | LGND | Sale | 3,335 | 160.90 | 536,604 |
2017-11-17 | LGND | Option Ex | 4,000 | 10.12 | 40,480 |
2017-11-17 | LGND | Sale | 4,000 | 139.79 | 559,160 |
2014-03-18 | LGND | Option Ex | 5,000 | 8.97 | 44,850 |
2014-03-18 | LGND | Sale | 5,000 | 78.83 | 394,150 |
2011-03-11 | LGND | Buy | 10,000 | 9.82 | 98,190 |
Table 2. Insider trading of Pfizer Inc (PFE) by Lamattina John L
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2007-06-15 | PFE | Sale | 36,066 | 26.48 | 955,027 |
2007-02-07 | PFE | Option Ex | 13,800 | 18.35 | 253,230 |
2007-02-07 | PFE | Sale | 13,800 | 26.54 | 366,252 |
2005-05-06 | PFE | Sale | 39,789 | 27.82 | 1,106,731 |
Table 3. Insider trading of Human Genome Sciences Inc (HGSI) by Lamattina John L
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2011-08-10 | HGSI | Option Ex | 12,009 | 2.09 | 25,098 |
2009-03-13 | HGSI | Buy | 10,000 | .72 | 7,190 |
2008-11-12 | HGSI | Buy | 20,000 | 2.19 | 43,700 |
Table 4. Insider trading of Immunome Inc. (IMNM) by Lamattina John L
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-05-24 | IMNM | Buy | 5,440 | 18.51 | 100,694 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lamattina John L
(Director of Ligand Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.